Published in Fertil Steril on April 01, 2002
Pre-analytical errors: everything that happens to the specimen up to the point of testing. Fertil Steril (2002) 0.75
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab (2006) 4.56
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab (2010) 2.48
A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology (2005) 2.43
Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J Clin Invest (2005) 1.86
Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev (2008) 1.66
The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun (2008) 1.61
The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun (2007) 1.55
Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker. Endocr Pract (2008) 1.51
The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology (2006) 1.49
Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet (2004) 1.47
Analysis of immune regulatory genes' copy number variants in Graves' disease. Thyroid (2010) 1.47
Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol (2011) 1.43
The genetic basis of thyroid autoimmunity. Thyroid (2007) 1.41
Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci U S A (2003) 1.41
HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J Autoimmun (2008) 1.35
The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun (2007) 1.25
Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J Clin Endocrinol Metab (2005) 1.16
Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves' disease. Thyroid (2006) 1.15
Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab (2007) 1.14
Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism. J Biol Chem (2011) 1.12
Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc Natl Acad Sci U S A (2008) 1.08
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause. Endocr Pract (2006) 1.07
The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA-DR3 positive AITD families. Clin Endocrinol (Oxf) (2002) 1.07
The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility. Autoimmun Rev (2003) 1.05
Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity. Autoimmun Rev (2004) 1.04
Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol (2007) 1.03
A multilocus model of the genetic architecture of autoimmune thyroid disorder, with clinical implications. Am J Hum Genet (2008) 1.03
Analysis of HLA genes in families with autoimmune diabetes and thyroiditis. Hum Immunol (2004) 1.01
Cutting edge: the etiology of autoimmune thyroid diseases. Clin Rev Allergy Immunol (2011) 1.00
Thyroid epigenetics: X chromosome inactivation in patients with autoimmune thyroid disease. Ann N Y Acad Sci (2007) 1.00
Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families. J Clin Endocrinol Metab (2009) 0.99
Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease. J Immunol (2012) 0.99
Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy. Thyroid (2008) 0.98
IFN-α mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms. J Immunol (2011) 0.98
'Linkage analysis of thyroid antibody production: evidence for shared susceptibility to clinical autoimmune thyroid disease. J Clin Endocrinol Metab (2008) 0.97
Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis. Proc Natl Acad Sci U S A (2010) 0.96
A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertil Steril (2002) 0.96
Clinical review: Clinical utility of TSH receptor antibodies. J Clin Endocrinol Metab (2013) 0.95
Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective. J Biol Chem (2009) 0.94
Analysis of immune regulatory genes in familial and sporadic Graves' disease. J Clin Endocrinol Metab (2004) 0.92
Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis. Thyroid (2013) 0.92
A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease. Thyroid (2002) 0.92
Hepatitis C and thyroid autoimmunity: is there a link? Am J Med (2004) 0.91
The mosaic of autoimmunity: genetic factors involved in autoimmune diseases--2008. Isr Med Assoc J (2008) 0.90
Obesity and the polycystic ovary syndrome. Med Clin North Am (2007) 0.89
Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril (2011) 0.88
Type 1 diabetes and autoimmune thyroiditis: the genetic connection. Thyroid (2009) 0.87
Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways. J Autoimmun (2013) 0.87
Tg.2098 is a major human thyroglobulin T-cell epitope. J Autoimmun (2010) 0.87
The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity (2003) 0.87
Genetic analysis in young-age-of-onset Graves' disease reveals new susceptibility loci. J Clin Endocrinol Metab (2014) 0.87
Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation. Ann N Y Acad Sci (2010) 0.86
Genetic and epigenetic mechanisms in thyroid autoimmunity. Immunol Res (2012) 0.85
Risk of cardiovascular events in mothers of women with polycystic ovary syndrome. Endocr Pract (2008) 0.84
CTLA-4 and autoimmune thyroid disease: lack of influence of the A49G signal peptide polymorphism on functional recombinant human CTLA-4. Cell Immunol (2002) 0.84
Susceptibility genes in thyroid autoimmunity. Clin Dev Immunol (2005) 0.84
The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation. Am J Transplant (2003) 0.83
Is there an association between acromegaly and thyroid carcinoma? A critical review of the literature. Endocr Res (2005) 0.83
Polycystic ovary syndrome, depression, and affective disorders. Endocr Pract (2009) 0.82
Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. Endocrine (2012) 0.82
The recent rise in the frequency of type 1 diabetes: who pulled the trigger? J Autoimmun (2011) 0.81
CTLA-4 gene exon-1 +49 A/G polymorphism: lack of association with autoimmune disease in patients with common variable immune deficiency. J Clin Immunol (2006) 0.80
FEM1A is a candidate gene for polycystic ovary syndrome. Gynecol Endocrinol (2005) 0.80
The effects of alpha interferon on the development of autoimmune thyroiditis in the NOD H2h4 mouse. Clin Dev Immunol (2004) 0.80
Update in thyroidology. J Clin Endocrinol Metab (2007) 0.80
Genetic susceptibility in thyroid autoimmunity. Pediatr Endocrinol Rev (2005) 0.80
Pancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metformin. Endocr Pract (2012) 0.79
What is the contribution of a Kozak SNP in the CD40 gene to Graves' disease? Clin Endocrinol (Oxf) (2005) 0.79
Endoplasmic reticulum stress as a novel mechanism in amiodarone-induced destructive thyroiditis. J Clin Endocrinol Metab (2015) 0.77
cDNA immunization of mice with human thyroglobulin generates both humoral and T cell responses: a novel model of thyroid autoimmunity. PLoS One (2011) 0.77
Apathetic thyrotoxicosis secondary to atypical subacute thyroiditis. Endocr Pract (2012) 0.75